1 / 6
Laboratory Research Material
Gonadorelin 2mg
- Compound
- Gonadorelin
- Amount per vial
- 2 mg
- Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Product Documentation
Details, specifications, and reviews
Description
Gonadorelin 2 mg: research material
Buy Gonadorelin 2 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.
Gonadorelin is a synthetic decapeptide corresponding to gonadotropin-releasing hormone, or GnRH. Its ten-residue structure makes it a defined material for investigating pituitary signaling and peptide structure–activity relationships.
Choose the material and presentation
This 2 mg listing is Gonadorelin research peptide in dry form. It is not a sublingual tablet or a prepared clinical formulation. The amount per vial describes labeled material mass, while 3 mL describes the container capacity; neither is a solution concentration.
Check the complete sequence, terminal chemistry and supplied chemical form when matching an experimental method. Modified GnRH agonists and antagonists are separate constructs. A salt designation in another supplier’s listing does not identify the form of this product.
Gonadorelin structure and GnRH signaling research
How the reference structure was established
Burgus and colleagues characterized ovine luteinizing hormone-releasing factor using enzymatic cleavage, sequencing and mass spectrometry. A synthesized decapeptide produced the same sequence result and the reported biological activities of the native material.
The reference has a pyroglutamyl N-terminus and an amidated C-terminus. Those structural features matter when comparing peptides; they should not be replaced by a name-only match. The study establishes molecular identity, rather than a clinical outcome from a catalog vial.
Read the original structure study
Exposure pattern changes the experimental question
Haisenleder and colleagues compared pulsatile and continuous GnRH exposure in a controlled rat model. They measured gonadotropin-subunit gene transcription in isolated pituitary nuclei. Responses depended on timing and differed between transcription measurements and cytoplasmic messenger RNA.
This is a reason to record exposure pattern and endpoint when comparing research findings. A result for LH or FSH gene expression is not interchangeable with a measurement of hormone release, and it does not establish fertility or testosterone benefits for this product.
Product records and batch reports
Review available batch reports and files in the product documentation section. Match the product and lot before interpreting a certificate of analysis (COA). Identity, chromatographic purity and measured content answer different questions and should be read separately.
Use the applicable material records for storage and handling. A published signaling experiment does not verify this lot’s solubility, shelf life or suitability for an assay.
Additional information
| CAS No. | 33515-09-2 |
|---|---|
| Purity | ≥99% |
| Sequence | pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 |
| Molecular Formula | C55H75N17O13 |
| Molecular Weight | 1182.31 g/mol |
| Applications | In-vitro assay research, compound characterization, analytical method development |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Independent lot testing
Gonadorelin 2mg Certificate of Analysis
This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.
- Lot number
- 35188
- Report number
- 39812
- Date tested
- September 15, 2026
- Reported purity
- 99.359%
- Labeled content
- 2 mg
Product documents
Product information and laboratory resources. For lot-specific results, use the COA above.
Product & packaging information
Labeled amount, physical form and packaging for Gonadorelin 2mg.
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Only logged in customers who have purchased this product may leave a review.
Need Assistance?
Questions about product documentation?
Our support team can assist with product records, lot information, order questions, and certificate verification.

There are no reviews yet.